• Skip to main content

ClinicalStudyConnect.com

Plain-Language Clinical Study and Ingredient Research

  • Heart & Blood Sugar
  • Bones & Joints
  • Everyday Vitamins
  • Reading Study Evidence
  • About

Lutein and Zeaxanthin Benefits: What Human Studies Show

posted on October 21, 2026

Lutein and zeaxanthin are carotenoids from food that collect in the macula, the small central part of your retina. Human studies show they can increase macular pigment optical density, or MPOD, in adults with healthy eyes; MPOD is a measurement of pigment in that part of the eye. Human research has also examined them for cataracts, dry eye, cognition, blood fats, and preterm infant outcomes, with results that vary by use.

If you are deciding whether an eye-health formula makes sense for you, start with the amount of each ingredient on its label and the outcome actually studied. Ingredient evidence vs marketing claims can help you separate an ingredient finding from a broader formula promise.

Quick facts: lutein and zeaxanthin at a glance

Question What human research covers
Forms studied Lutein and zeaxanthin from dietary interventions, supplements, and combinations that also included meso-zeaxanthin.
Doses studied Total lutein/zeaxanthin intakes below 5 mg daily, 5 to under 20 mg daily, and 20 mg or more daily; one large eye trial used 10 mg lutein plus 2 mg zeaxanthin daily.
Typical study length Many healthy-eye studies lasted 3 to 12 months. Dry-eye trials lasted 4 to 12 weeks.
Main studied uses Macular pigment in healthy adults, cataract outcomes, dry-eye measures, cognition, blood lipids, and outcomes in preterm infants.
Food sources Green leafy vegetables, egg yolks, corn, and squash are listed in the healthy-eye review. Spinach, broccoli, zucchini, Romaine lettuce, peas, and egg yolks are also listed by Tufts Nutrition Letter.

What do human studies show?

Macular pigment in adults with healthy eyes

The strongest body of evidence is a systematic review and meta-analysis of 46 studies involving 3,189 adults with healthy eyes. It found no statistically significant MPOD change in studies using less than 5 mg daily, largely dietary interventions lasting 3 to 6 months. In studies using 5 to under 20 mg daily for 3 to 12 months, the pooled MPOD increase was 0.04 units; at 20 mg or more daily, it was 0.11 units. Read the healthy-eye MPOD review for the full methods and results.

MPOD is a biological measurement, not a guarantee of sharper vision or a particular eye outcome. The review found the effect on visual function remained unclear.

Cataract outcomes and vision loss

In the AREDS2 double-masked randomized trial, 4,203 adults ages 50 to 85 years who were at risk of progression to advanced age-related macular degeneration received different study assignments, including 10 mg lutein plus 2 mg zeaxanthin daily. Among 3,159 participants with a natural lens in at least one eye, the five-year probability of cataract surgery was 24% both with and without lutein/zeaxanthin. The trial also found no statistically significant effect on moderate or worse vision loss. The AREDS2 cataract trial reported no clinically or statistically significant serious adverse effect associated with its treatments.

Dry-eye symptoms and tear-film measures

A systematic review of six randomized controlled trials involving 584 people with dry eye studied lutein doses from 3 to 20 mg daily for 4 to 12 weeks. Some trials found lower symptom scores and longer tear break-up time, while others found no meaningful difference from control. The review concluded that larger, better-designed trials are needed to confirm the finding and establish a standard study dose.

Preterm infant outcomes

A 2025 Cochrane review pooled five studies with 666 preterm infants given lutein and zeaxanthin from day one of life until hospital discharge. The review found that supplementation probably reduced retinopathy of prematurity stage 3 or above, but probably had little or no effect on retinopathy at any stage. It also found little or no effect on mortality, intraventricular hemorrhage, or necrotising enterocolitis; no adverse effects were reported. These are hospital-based newborn studies, not evidence for self-selected supplements in older children or adults. See the Cochrane preterm-infant review.

Cognition and memory

A meta-analysis of placebo-controlled adult trials found small, non-significant changes in complex attention, executive function, and memory with dietary lutein. Its change-from-baseline analysis suggested a possible role in maintaining memory and executive function, but the researchers called for more intervention studies. The adult cognition meta-analysis explains the results.

Blood lipids

A meta-analysis of intervention studies found no meaningful overall effect of lutein/zeaxanthin on total cholesterol or LDL cholesterol. It reported a statistically significant rise in HDL cholesterol among older adults, but this was not a basis for using the ingredients in place of prescribed cholesterol care.

What doses have researchers used?

These are research doses, not personal dosing advice. The healthy-eye review grouped total daily lutein/zeaxanthin intake as below 5 mg, 5 to under 20 mg, and 20 mg or more, usually over 3 to 12 months. AREDS2 used 10 mg lutein plus 2 mg zeaxanthin daily. Dry-eye trials used 3 to 20 mg of lutein daily for 4 to 12 weeks.

Many eye formulas contain other nutrients as well. If you want to understand the evidence for a combination label, zinc benefits doses studied safety evidence explains why each listed ingredient needs its own evidence and dose context.

Safety, side effects, and medicine interactions

In the AREDS2 cataract analysis, daily lutein/zeaxanthin treatment was not associated with a clinically or statistically significant serious adverse effect. The Cochrane review of preterm-infant trials likewise recorded no adverse effects in either study group.

Safety question What the human studies say
Serious side effects None were associated with treatment in the AREDS2 cataract analysis.
Preterm infants The Cochrane review reported no adverse effects in the included trials.
Medicine combinations Bring the exact label to a pharmacist or clinician, especially when a formula contains several nutrients or you use prescribed medicine.

Who should talk to a clinician first?

Talk to a clinician before using a lutein or zeaxanthin supplement for a child, during pregnancy or breast-feeding, or alongside prescribed medicine. A clinician can help you match the question you have—such as a new vision change, dry-eye symptoms, or a diagnosed eye condition—to appropriate care instead of relying on a supplement label alone.

What is still unknown?

Higher-dose studies in healthy adults show higher MPOD, but it remains unclear whether that change produces a clinically important improvement in visual function. The effect of food-based intakes below 5 mg daily is less clear, and the healthy-eye review found no studies assessing 5 to 10 mg daily for MPOD.

How do you read a lutein and zeaxanthin label?

Start with the Supplement Facts panel rather than the front-label promise. Look for the amount of lutein and zeaxanthin listed separately, then compare those amounts with the doses researchers actually used.

Label detail Why it matters
Amount of lutein Lets you see whether the label states a specific daily amount rather than only naming the ingredient.
Amount of zeaxanthin AREDS2 studied 2 mg zeaxanthin alongside 10 mg lutein; other studies used different total amounts.
Meso-zeaxanthin This is an isomer of zeaxanthin found in some study formulas. Mixed results mean its presence alone does not settle what outcome you should expect.
Proprietary blend A blend that gives only a combined total does not let you compare each ingredient with the amounts used in human studies.
Other nutrients Vitamin and mineral additions may matter for safety and for interpreting what was actually studied.

A clear label gives you the ingredient form and amount per daily serving. That makes it easier to compare the formula with the study question you care about, without confusing an ingredient result with a promise about the whole product.

By ClinicalStudyConnect.com Research Desk

This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.

Related reading

  1. Niacin Benefits: What Human Studies Show, Doses and Safety
  2. L-Carnitine Benefits: What Human Studies Show, Doses and Safety
  3. Magnesium Benefits: What Human Studies Show, Doses and Safety
  4. Vitamin C Benefits: What Human Studies Show, Doses, Safety

Clinical Study Connect

Plain-Language Clinical Study and Ingredient Research

Topics

  • Research Guides
  • Ingredient Evidence
  • Study Design
  • Emerging Research
  • Safety

Publication

  • Editorial Standards
  • Research Methodology
  • Contact

Policies

  • Medical Disclaimer
  • Privacy Policy
© 2026 Clinical Study ConnectFor information only, not medical advice. See our Medical Disclaimer.